Milder Heart Failure Might Benefit From Implantable Monitors Randomized trial signals benefit, albeit hampered by the pandemic Aug 27, 2021
Deadly Arrhythmias Less of a Risk for HF Patients on Dapagliflozin DAPA-HF analysis further explores mechanism of SGLT2 inhibitor's heart benefits Aug 27, 2021
Heart Failure Again Takes Center Stage at ESC EMPEROR-Preserved, new guidelines, and more to come Aug 26, 2021
Inotrope Showdown Leaves No Winner in Cardiogenic Shock Long-awaited head-to-head comparison of milrinone and dobutamine Aug 04, 2021
TAVR Debris Deflector Doesn't Fly With FDA Advisory Panel TriGuard 3 met with skepticism in its bid for approval Aug 04, 2021
Start Rhythm Control Early for Afib With Heart Failure EAST-AFNET 4 trial finds similar benefits across ejection fraction ranges Jul 31, 2021
SGLT2 Inhibitor Adds Years of Life to Patients With Heart Failure DAPA-HF group makes projections as long-term data are lacking Jul 28, 2021
Changes in Epicardial Fat May Drive SGLT2 Inhibitor Benefits More insight into mechanisms behind empagliflozin's cardioprotection Jul 26, 2021
Surprising Tradeoffs of Valve-in-Valve TAVR vs Redo Surgery Observational study suggests excess readmissions with less invasive procedure Jul 23, 2021
Does COAPT Change the Need to Try Foundational HF Drugs in Functional MR? Current GDMT titration approach under fire during TVT debate Jul 21, 2021
After Some Early Successes for Bicuspid TAVR, a Randomized Trial May Be Unlikely Are observational data on highly selected patients good enough? Jul 21, 2021
Scarring on an Otherwise Normal Heart: Reassuring Data Emerge Phenomenon tied to very low burden of major arrhythmic events Jul 14, 2021
Trouble Looms With Pacemakers After Aortic Valve Replacement Permanent pacemaker implantation of clinical significance in cohort study Jul 13, 2021
Academic Cardiologists Singled Out for Gender Equality Problem Women still poorly represented, paid in procedural internal medicine specialties Jul 12, 2021
Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Says New phenomenon suggests perils of not performing biopsy in time Jul 07, 2021
Regenerative Therapy Makes Headway in HF ... in the Right Patients Study of autologous skeletal cell-patch implantation in Japan Jul 02, 2021
First TTS Case After mRNA Shot; Fake Fellow Strikes Out; Disappearing Pacemaker Recent developments of interest in cardiovascular medicine Jun 29, 2021
First Close Look at Presumed Myocarditis Cases After COVID Vaccination Case reports suggest a favorable clinical course after hospitalization Jun 17, 2021
Early Vax Myocarditis Data; Novel RAAS Inhibitor; Star Athletes Collapse Mid-Game Recent developments of interest in cardiovascular medicine Jun 14, 2021
Op-Ed: Does Your Patient Really Have Diastolic Dysfunction? The Skeptical Cardiologist highlights the confusion in "diastology" Jun 05, 2021
Medtronic's LVAD Pulled From Market Due to Neurological, Mortality Risks Physicians must stop implanting the HeartWare system, says FDA Jun 03, 2021
Passing Early-Term Report Cards for New Mitral, Tricuspid Valve Interventions A glance at devices coming down the structural heart pipeline in the coming years May 24, 2021
Navitor Shuts Out Leaky TAVR, but Pacemaker Rates a Concern? 30-day data for a new version of the Portico valve May 20, 2021
Adverse Events Drop With Fuller Accounting of Evolut Low Risk Trial Yet worrying signals with TAVR remain May 19, 2021
Novel Heart Failure Agent Works Best in Sickest Patients Omecamtiv mecarbil provides benefit to those with low LVEF May 18, 2021
Entresto Risky for Advanced Heart Failure? LIFE trial "not only disappointed but surprised" with its findings May 17, 2021
Pacemaker Interference Warning; Religious Fasting and CVD; Toothpick in the Heart Recent developments of interest in cardiovascular medicine May 17, 2021
Stubborn Gaps in Heart Failure Persist Despite Clinician Education, Feedback Guideline-directed medical therapy underuse still a problem in CONNECT-HF trial May 17, 2021
Personalized Rehab Helpful in Heart Failure Patients Trial showed improvements in physical functioning and quality of life compared with usual care May 17, 2021
Mixed Results with ARNI Therapy for Post-MI Heart Failure Prevention Sacubitril/valsartan deemed safe, but still can't beat ramipril in PARADISE-MI trial May 15, 2021
Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathy Secondary findings show big gains for more than a third of patients May 15, 2021
ARNI Therapy in the Hot Seat at Another Virtual ACC PARADISE-MI to provide data on Entresto for MI survivors with reduced LVEF May 14, 2021
COVID Vax & Myocarditis; Ejection Fractions on EKG; Southerners Still Unwell Recent developments of interest in cardiovascular medicine May 10, 2021
Surgical Repair: A Newcomer in Aortic Valve Disease In this podcast, Andrew Perry and Chris Burke tackle the current state of aortic valve repair May 07, 2021 podcast
What's Behind the Mysterious Chest Pain in Bladder Cancer Patient? Cardiomyopathy risks interrupting cancer treatment, worsening prognosis May 03, 2021
Farxiga Gets FDA Greenlight for CKD SGLT2 OK'd to prevent chronic kidney disease progression and cardiovascular risks Apr 30, 2021
Endocarditis After Low-Risk TAVR: Different Trajectory, Problem Organisms Low-risk patients "not immune" to rare infection, LRT studies show Apr 30, 2021
Heart Pump Protocol Makes a Dent in Cardiogenic Shock Mortality NCSI algorithm includes early hemodynamic support Apr 29, 2021
Post-MitraClip Gradients Not So Dangerous After All COAPT analysis suggests benefit of MR reduction offsets risk of mitral stenosis Apr 19, 2021
